New COVID-19 drug trial could help people recover faster
Researchers from The Alfred and Monash University have set out to determine whether an antiviral medication that has activity against COVID-19 could help clear the virus more quickly and also help people recover from the illness.
Led by researcher and Infectious Diseases specialist Dr James McMahon, the VIRCO trial, is currently enrolling symptomatic people with COVID-19 in the first five days of diagnosis to trial an antiviral drug called Favipiravir, which was originally developed to treat people with influenza. Favipiravir is currently being studied in multiple countries for COVID-19 including the United States and Japan, and with this trial is now being studied in Australia.
Read the full story here.